Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 12-2022 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 0 | 24,210 |
| Marketable Securities | 0 | 18,251 |
| Other current assets | 0 | 1,750 |
| TOTAL | $0 | $44,211 |
| Non-Current Assets | ||
| PPE Net | N/A | 577 |
| Other Non-Current Assets | 0 | 42 |
| TOTAL | $N/A | $619 |
| Total Assets | $0 | $45,095 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 0 | 976 |
| Accrued Expenses | 0 | 2,318 |
| TOTAL | $0 | $3,431 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 0 | 83,945 |
| TOTAL | $N/A | $83,945 |
| Total Liabilities | $0 | $87,700 |
| Shareholders' Equity | ||
| Common Shares | 0 | 1 |
| Retained earnings | 0 | -43,020 |
| Other shareholders' equity | 0 | 3 |
| TOTAL | $0 | $-42,605 |
| Total Liabilities And Equity | $0 | $45,095 |